IL24 and metabolic dysfunction-associated steatotic liver disease: Moreover, a further significant decrease in serum IL-24 (116.02 [95.48–135.75]) was observed in MASLD patients with concomitant transaminitis compared to those with MASLD alone (P < 0.0001).